Amgen Inc Bei Gene, Ltd. (BGNE) insider trading activity
Amgen Inc is > 10% Shareholder of BeiGene, Ltd.. Currently has a direct ownership of 18.9 Million shares of BGNE, which is worth approximately $3.84 Billion. The most recent transaction as insider was on Sep 10, 2021, when has been sold 165,529 shares (American Depositary Shares) at a price of $302.06 per share, resulting in proceeds of $49,999,689. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
18.9M
0%
3M change
0%
12M change
Total Value Held
$3.84 Billion
AMGEN INC Transaction History
Also insider at
AI
Amgen Inc
> 10% Shareholder
Thousand Oaks, CA